Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now early-phase tilt small index

Ureteral Diseases: early-phase trial registry

2 of 3 indexed Ureteral Diseases trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #5,209 of 28,707 conditions by registered trial count.

3 US clinical trials · 2 currently recruiting · #5,209 of 28,707 conditions by registered trial count

Ureteral Diseases: 3 US clinical trials tracked, 2 recruiting.

Ureteral Diseases is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Adva-Tec, running 1 of these trials.

Enrollment posture brief

Registry condition ureteral-diseases

OPEN 2 | RECR 67% | LATE 0 | EARLY 1 | RANK #5209 | SPON 1

Nearest open-share peer: Acute Hypoxemic Respiratory Failure (67% recruiting · 6 trials)

Ablation80%ACL Reconstruction80%Ureteral Diseases (this)67%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Ureteral Diseases

Ureteral Diseases lists 2 open slots (67% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Ureteral Diseases on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Ureteral Diseases is recruiting above its size-band peers.

    2 of 3 indexed trials (66.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 21

Phase Distribution

PhaseTrial count
Phase 2 1

Named interventions

Most-linked intervention names on Ureteral Diseases records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

observed levels of pain Behavioral
1 trials
Oxybutynin Drug
1 trials
Methocarbamol Drug
1 trials
Uriprene® Degradable Temporary Ureteral Stent Device
1 trials

US sites by state

Facility locations filed on Ureteral Diseases trials. A trial with sites in several states counts in each.

Ohio 1 trials
Missouri 1 trials
Illinois 1 trials
Florida 1 trials
California 1 trials
Arizona 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Ureteral Diseases page

3 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 2 Ureteral Diseases trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Adva-Tec sponsors the most Ureteral Diseases trials on record, review their full trial history before evaluating a specific study. See Adva-Tec's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Ureteral Diseases condition card totals 3 registered trials; most-linked intervention observed levels of pain; top US site state Ohio. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.